These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
25. Significance and Implications of Patient-reported Xerostomia in Sjögren's Syndrome: Findings From the National Institutes of Health Cohort. Billings M; Dye BA; Iafolla T; Baer AN; Grisius M; Alevizos I EBioMedicine; 2016 Oct; 12():270-279. PubMed ID: 27639822 [TBL] [Abstract][Full Text] [Related]
26. Validation of the Sicca Symptoms Inventory for clinical studies of Sjögren's syndrome. Bowman SJ; Booth DA; Platts RG; Field A; Rostron J; J Rheumatol; 2003 Jun; 30(6):1259-66. PubMed ID: 12784400 [TBL] [Abstract][Full Text] [Related]
27. Lymphocytic infiltration and enlargement of the lacrimal glands: a new subtype of primary Sjögren's syndrome? Parkin B; Chew JB; White VA; Garcia-Briones G; Chhanabhai M; Rootman J Ophthalmology; 2005 Nov; 112(11):2040-7. PubMed ID: 16168486 [TBL] [Abstract][Full Text] [Related]
28. Involvement of Aquaporins in the Pathogenesis, Diagnosis and Treatment of Sjögren's Syndrome. Soyfoo MS; Chivasso C; Perret J; Delporte C Int J Mol Sci; 2018 Oct; 19(11):. PubMed ID: 30380700 [TBL] [Abstract][Full Text] [Related]
29. Low tear production in patients with diabetes mellitus is not due to Sjögren's syndrome. Ramos-Remus C; Suarez-Almazor M; Russell AS Clin Exp Rheumatol; 1994; 12(4):375-80. PubMed ID: 7955600 [TBL] [Abstract][Full Text] [Related]
30. Assessment of the European classification criteria for Sjögren's syndrome in a series of clinically defined cases: results of a prospective multicentre study. The European Study Group on Diagnostic Criteria for Sjögren's Syndrome. Vitali C; Bombardieri S; Moutsopoulos HM; Coll J; Gerli R; Hatron PY; Kater L; Konttinen YT; Manthorpe R; Meyer O; Mosca M; Ostuni P; Pellerito RA; Pennec Y; Porter SR; Richards A; Sauvezie B; Schiødt M; Sciuto M; Shoenfeld Y; Skopouli FN; Smolen JS; Soromenho F; Tishler M; Wattiaux MJ Ann Rheum Dis; 1996 Feb; 55(2):116-21. PubMed ID: 8712861 [TBL] [Abstract][Full Text] [Related]
31. Urolithiasis and distal renal tubular acidosis preceding primary Sjögren's syndrome: a retrospective study 5-53 years after the presentation of urolithiasis. Eriksson P; Denneberg T; Eneström S; Johansson B; Lindström F; Skogh T J Intern Med; 1996 Jun; 239(6):483-8. PubMed ID: 8656141 [TBL] [Abstract][Full Text] [Related]
32. Salivary gland and peripheral blood T helper 1 and 2 cell activity in Sjögren's syndrome compared with non-Sjögren's sicca syndrome. van Woerkom JM; Kruize AA; Wenting-van Wijk MJ; Knol E; Bihari IC; Jacobs JW; Bijlsma JW; Lafeber FP; van Roon JA Ann Rheum Dis; 2005 Oct; 64(10):1474-9. PubMed ID: 15817659 [TBL] [Abstract][Full Text] [Related]
33. [Anti-SS-B antibody : marker of Gougerot-Sjögren's connective tissue disease independent of the dry syndrome]. Abuaf N; Fitoussi C; Riou AM; Homberg JC Rev Med Interne; 1983 Dec; 4(4):369-72. PubMed ID: 6607495 [TBL] [Abstract][Full Text] [Related]
34. Clinical and immunological parameters of Sjögren's syndrome. Psianou K; Panagoulias I; Papanastasiou AD; de Lastic AL; Rodi M; Spantidea PI; Degn SE; Georgiou P; Mouzaki A Autoimmun Rev; 2018 Oct; 17(10):1053-1064. PubMed ID: 30103041 [TBL] [Abstract][Full Text] [Related]
35. Update in Sjögren syndrome. Fox RI; Stern M; Michelson P Curr Opin Rheumatol; 2000 Sep; 12(5):391-8. PubMed ID: 10990175 [TBL] [Abstract][Full Text] [Related]
36. Autonomic failure and proximal skeletal myopathy in a patient with primary Sjögren syndrome. Sorajja P; Poirier MK; Bundrick JB; Matteson EL Mayo Clin Proc; 1999 Jul; 74(7):695-7. PubMed ID: 10405700 [TBL] [Abstract][Full Text] [Related]
37. The spectrum of immune-mediated autonomic neuropathies: insights from the clinicopathological features. Koike H; Watanabe H; Sobue G J Neurol Neurosurg Psychiatry; 2013 Jan; 84(1):98-106. PubMed ID: 22906617 [TBL] [Abstract][Full Text] [Related]